Caristo’s coronary inflammation technology identified cardiovascular risk missed by conventional [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]
Caristo’s coronary inflammation technology identified cardiovascular risk missed by conventional [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]